Aortic Stent Grafts Market Size, Share, Growth, and Industry Analysis, By Type ( Endovascular Aneurysm Repair(EVAR),Abdominal Aortic Aneurysm Repair,Other ), By Application ( Hospitals,Clinics,Ambulatory Surgical Centers ), Regional Insights and Forecast to 2035

Aortic Stent Grafts Market Overview

Global Aortic Stent Grafts market size is anticipated to be worth USD 2465.8 million in 2026, projected to reach USD 4175.4 million by 2035 at a 6% CAGR.

The Aortic Stent Grafts Market is driven by the increasing prevalence of aortic aneurysms, affecting approximately 5–10% of individuals aged over 65 years globally. Endovascular procedures account for nearly 70% of aortic aneurysm repairs, replacing open surgeries due to lower complication rates. Stent graft implantation reduces hospital stays by approximately 40–60%, with procedural success rates exceeding 95%. Approximately 200,000 aortic aneurysm repairs are performed annually worldwide, with endovascular techniques used in over 60% of cases. Technological advancements have improved graft durability, with devices lasting more than 10–15 years, supporting long-term patient outcomes and increasing adoption in the Aortic Stent Grafts Market.

In the United States, the Aortic Stent Grafts Market is supported by high incidence rates, with over 200,000 people diagnosed with abdominal aortic aneurysms annually. Approximately 15,000 deaths per year are attributed to aortic aneurysm rupture in the U.S. Endovascular aneurysm repair (EVAR) procedures account for nearly 75% of all aortic repairs, reflecting strong adoption of minimally invasive techniques. The U.S. performs over 100,000 EVAR procedures annually, with hospital stays reduced by approximately 50% compared to open surgery. Additionally, over 65% of patients aged above 65 years are eligible for stent graft procedures, supporting growth in the Aortic Stent Grafts Market.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Over 58% increase in minimally invasive procedures, 46% rise in aging population, 39% growth in aortic aneurysm incidence, and 42% increase in early diagnosis rates driving Aortic Stent Grafts Market Growth.
• Major Market Restraint: Around 44% of procedures face high device costs, 33% report post-surgical complications, 29% experience device-related issues, and 36% of patients have anatomical limitations impacting Aortic Stent Grafts Market Size.
• Emerging Trends: Nearly 37% adoption of advanced stent graft designs, 31% integration with imaging technologies, 26% use of customized graft solutions, and 34% increase in hybrid surgical approaches shaping Aortic Stent Grafts Market Trends.
• Regional Leadership: North America holds 38% share, Europe accounts for 30%, Asia-Pacific contributes 24%, and Middle East & Africa represent 8% in Aortic Stent Grafts Market Share distribution.
• Competitive Landscape: Top 5 companies control 60% share, mid-tier players account for 25%, and smaller manufacturers hold 15%, reflecting Aortic Stent Grafts Market Insights on competition.
• Market Segmentation: EVAR procedures dominate with 65% share, abdominal aortic aneurysm repair accounts for 25%, and others contribute 10%, while hospitals represent 70%, clinics 20%, and ambulatory centers 10% in Aortic Stent Grafts Market Analysis.
• Recent Development: Around 35% of innovations focus on improved graft flexibility, 28% enhance durability, 24% improve deployment accuracy, and 32% integrate imaging compatibility in Aortic Stent Grafts Market Outlook.

Aortic Stent Grafts Market Latest Trends

Aortic Stent Grafts Market Trends highlight the increasing adoption of minimally invasive procedures, with endovascular aneurysm repair (EVAR) used in approximately 70–75% of cases globally. These procedures reduce recovery time by nearly 50%, improving patient outcomes. Technological advancements have led to the development of stent grafts with improved flexibility and durability, with device lifespan exceeding 10–15 years. Additionally, approximately 37% of new stent graft designs incorporate advanced materials that enhance performance.

Aortic Stent Grafts Market Analysis shows that imaging technologies, such as CT and MRI, are used in nearly 80% of procedures, improving accuracy and reducing complications by approximately 20%. Customized stent graft solutions are adopted in approximately 26% of cases, addressing patient-specific anatomical challenges. Hybrid surgical approaches, combining open and endovascular techniques, are used in nearly 30% of complex cases, improving success rates. Aortic Stent Grafts Market Insights indicate that the aging population, with over 700 million people aged above 65 globally, is a key factor driving demand. Additionally, early diagnosis rates have increased by approximately 40%, supporting timely treatment and market expansion.

Aortic Stent Grafts Market Dynamics

Aortic Stent Grafts Market Dynamics are driven by the increasing prevalence of aortic aneurysms, affecting approximately 5–10% of individuals aged over 65 years, while the global elderly population exceeds 700 million, increasing demand for vascular treatments. Endovascular aneurysm repair (EVAR) is used in nearly 70–75% of procedures, reducing recovery time by approximately 50% and lowering mortality rates by nearly 20–30% compared to open surgery. Additionally, early diagnosis rates have improved by approximately 40%, supporting timely interventions. However, nearly 44% of patients face high procedural costs, and post-operative complications occur in approximately 20–30% of cases, limiting adoption. Technological advancements, including customized stent grafts used in approximately 26% of procedures and imaging integration in nearly 32%, enhance accuracy and outcomes. Limited access to advanced healthcare affects nearly 50% of patients in developing regions, influencing Aortic Stent Grafts Market Growth.

DRIVER

"Rising prevalence of aortic aneurysms and aging population"

The Aortic Stent Grafts Market Growth is driven by increasing incidence of aortic aneurysms, affecting approximately 5–10% of individuals over 65 years. The global aging population exceeds 700 million people, increasing demand for vascular treatments. EVAR procedures, used in nearly 70–75% of cases, offer reduced recovery times and lower complication rates. Additionally, early diagnosis rates have increased by approximately 40%, supporting timely intervention. These factors collectively drive market expansion.

RESTRAINT

"High costs and procedural complications"

Aortic Stent Grafts Market Restraints include high device costs, with procedures costing approximately 30–50% more than traditional treatments. Nearly 44% of patients face affordability challenges. Post-surgical complications occur in approximately 20–30% of cases, affecting outcomes. Additionally, anatomical limitations impact nearly 36% of patients, restricting eligibility for stent graft procedures. These factors limit market growth.

OPPORTUNITY

"Technological advancements and customized solutions"

Aortic Stent Grafts Market Opportunities are driven by advancements in device design, with approximately 37% of new products featuring improved flexibility and durability. Customized stent grafts are used in nearly 26% of cases, addressing complex anatomies. Imaging technologies, used in approximately 80% of procedures, improve accuracy and reduce complications. These innovations support market growth.

CHALLENGE

"Limited access in developing regions"

Aortic Stent Grafts Market Challenges include limited access to advanced healthcare, affecting nearly 50% of patients in developing regions. Lack of trained professionals impacts approximately 30% of procedures, reducing adoption. Additionally, infrastructure limitations affect nearly 25% of healthcare facilities, restricting availability of advanced treatments. These challenges influence market expansion.

Aortic Stent Grafts Market Segmentation

The Aortic Stent Grafts Market Segmentation is categorized by type and application, with EVAR procedures leading at approximately 65% market share, followed by abdominal aortic aneurysm repair at 25%, and others at 10%. By application, hospitals dominate with nearly 70% share, followed by clinics at 20% and ambulatory surgical centers at 10%. Increasing prevalence of aortic aneurysms, affecting 5–10% of elderly populations, drives segmentation growth. Aortic Stent Grafts Market Size and Share vary based on treatment type and healthcare infrastructure.

Download Free Sample to learn more about this report.

By Type

Endovascular Aneurysm Repair (EVAR): Endovascular Aneurysm Repair (EVAR) dominates the Aortic Stent Grafts Market with approximately 65% market share, as it is the preferred minimally invasive procedure for treating aortic aneurysms. EVAR procedures reduce hospital stay duration by nearly 40–60% compared to open surgery and lower perioperative mortality rates by approximately 20–30%. Globally, over 150,000 EVAR procedures are performed annually, accounting for nearly 70–75% of total aortic repairs. Aortic Stent Grafts Market Trends indicate that EVAR adoption has increased by approximately 35% over the past decade, driven by technological advancements. Additionally, procedural success rates exceed 95%, while complication rates are reduced by approximately 25%, supporting widespread use in clinical practice.

Abdominal Aortic Aneurysm Repair: Abdominal Aortic Aneurysm (AAA) Repair accounts for approximately 25% of the Aortic Stent Grafts Market Share, focusing on treatment of aneurysms located in the abdominal region. Approximately 80% of aortic aneurysms occur in the abdominal aorta, making this segment highly significant. AAA repair procedures exceed 200,000 cases annually worldwide, with nearly 60–70% treated using stent grafts. Aortic Stent Grafts Market Analysis shows that early detection improves survival rates by approximately 40%, while EVAR-based AAA repairs reduce recovery time by nearly 50%. Additionally, screening programs targeting populations over 65 years have increased diagnosis rates by approximately 30%, supporting growth in this segment.

Other Aortic Stent Graft Types: Other stent graft types, including thoracic and hybrid grafts, account for approximately 10% of the Aortic Stent Grafts Market Size. Thoracic aortic aneurysms represent nearly 20% of all aortic aneurysm cases, requiring specialized stent grafts. Hybrid procedures combining open surgery and endovascular techniques are used in approximately 30% of complex cases, improving treatment outcomes. Aortic Stent Grafts Market Insights indicate that advanced graft designs improve flexibility by approximately 25%, enhancing performance in challenging anatomies. Additionally, these systems are used in nearly 15% of high-risk patients, providing alternative treatment options where traditional methods are not suitable.

By Application

Hospitals: Hospitals dominate the Aortic Stent Grafts Market with approximately 70% market share, as they provide advanced infrastructure and specialized surgical expertise. Over 80% of EVAR procedures are performed in hospital settings due to availability of imaging technologies such as CT and MRI, used in nearly 85% of procedures. Hospitals perform more than 150,000 aortic repair surgeries annually, with stent graft procedures accounting for a significant portion. Aortic Stent Grafts Market Trends indicate that hospitals achieve success rates exceeding 95%, supported by multidisciplinary teams. Additionally, nearly 60% of hospitals have dedicated vascular surgery units, improving patient outcomes and driving segment growth.

Clinics: Clinics account for approximately 20% of the Aortic Stent Grafts Market Share, focusing on diagnosis, follow-up care, and minor procedures. Approximately 40% of patients receive initial diagnosis and monitoring in clinical settings. Clinics play a critical role in early detection, with screening programs increasing diagnosis rates by approximately 30%. Aortic Stent Grafts Market Analysis shows that clinics contribute to reducing complications by approximately 20% through regular monitoring and timely referrals. Additionally, nearly 50% of patients undergo post-operative follow-ups in clinics, ensuring long-term success of stent graft procedures.

Ambulatory Surgical Centers (ASCs): Ambulatory Surgical Centers (ASCs) represent approximately 10% of the Aortic Stent Grafts Market Size, with growing adoption of minimally invasive procedures. ASCs reduce procedure costs by approximately 20–30% compared to hospital settings, making them attractive for certain patient groups. Nearly 15% of EVAR procedures are performed in ASCs, particularly in developed regions. Aortic Stent Grafts Market Insights indicate that ASCs improve patient turnover rates by approximately 25%, enhancing operational efficiency. Additionally, advancements in portable imaging technologies support the expansion of ASCs, contributing to segment growth.

Regional Outlook for the Aortic Stent Grafts Market

Aortic Stent Grafts Market Regional Outlook shows North America leading with approximately 38% market share, supported by over 100,000 EVAR procedures annually and advanced healthcare infrastructure with more than 6,000 hospitals equipped for vascular treatments. Europe follows with around 30% share, performing over 80,000 procedures annually, with nearly 70% utilizing stent grafts. Asia-Pacific accounts for approximately 24% share, driven by a population exceeding 4.5 billion and increasing healthcare investments, with over 60,000 procedures annually and adoption rates rising by approximately 25% over the past decade. The Middle East & Africa represent approximately 8% share, with over 20,000 procedures annually and improving healthcare access, increasing adoption by nearly 15%. Across all regions, EVAR procedures account for approximately 70–75% of treatments, while early diagnosis rates have increased by approximately 30–40%, supporting Aortic Stent Grafts Market Trends globally.

Download Free Sample to learn more about this report.

North America

North America leads the Aortic Stent Grafts Market with approximately 38% market share, supported by advanced healthcare infrastructure and high adoption of minimally invasive procedures. The region performs over 100,000 EVAR procedures annually, with the United States accounting for nearly 85% of regional demand. Aortic Stent Grafts Market Insights indicate that nearly 75% of aortic repairs in North America use stent grafts, reflecting strong preference for endovascular techniques. The region has over 6,000 hospitals equipped with advanced imaging technologies, enabling accurate diagnosis and treatment. Early screening programs have increased detection rates by approximately 35%, supporting timely intervention. Aortic Stent Grafts Market Trends show that nearly 40% of procedures involve advanced graft designs, improving patient outcomes. Additionally, healthcare spending on cardiovascular treatments represents nearly 20% of total healthcare expenditure, supporting market growth.

Europe

Europe accounts for approximately 30% of the Aortic Stent Grafts Market Share, with strong adoption of EVAR procedures across countries such as Germany, France, and the United Kingdom. The region performs over 80,000 aortic repair procedures annually, with nearly 70% using stent grafts. Aortic Stent Grafts Market Analysis indicates that early diagnosis programs have increased detection rates by approximately 30%, improving treatment outcomes. Approximately 65% of hospitals in Europe have specialized vascular units, supporting advanced procedures. Aortic Stent Grafts Market Trends show that nearly 35% of new stent grafts incorporate advanced materials, improving durability and flexibility. Additionally, aging population, with over 20% of people aged above 65, drives demand for aortic treatments. The region’s focus on healthcare innovation supports market expansion.

Asia-Pacific

Asia-Pacific holds approximately 24% of the Aortic Stent Grafts Market Size, driven by a large population exceeding 4.5 billion and increasing prevalence of cardiovascular diseases. The region performs over 60,000 aortic repair procedures annually, with adoption of EVAR increasing by approximately 25% over the past decade. Countries such as China, Japan, and India contribute nearly 70% of regional demand. Aortic Stent Grafts Market Growth is supported by rising healthcare investments, increasing by approximately 20% over the past decade. Additionally, nearly 40% of hospitals in the region are adopting advanced imaging technologies, improving diagnosis and treatment accuracy. Aortic Stent Grafts Market Insights indicate that early detection programs have increased diagnosis rates by approximately 25%, supporting market growth.

Middle East & Africa

The Middle East & Africa region accounts for approximately 8% of the Aortic Stent Grafts Market Share, with growing adoption of advanced vascular treatments. The region performs over 20,000 aortic repair procedures annually, with EVAR adoption increasing by approximately 15% over the past decade. Countries such as Saudi Arabia and the UAE contribute nearly 60% of regional demand. Aortic Stent Grafts Market Analysis shows that healthcare infrastructure improvements have increased access to advanced treatments by approximately 20%. Additionally, nearly 30% of hospitals in the region are equipped with advanced imaging technologies, supporting diagnosis and treatment. Aortic Stent Grafts Market Trends indicate that awareness programs have increased early detection rates by approximately 20%, driving market growth.

List of Top Aortic Stent Grafts Companies

• Medtronic
• Cook Medical
• Cordis
• Gore Medical
• Lombard Medical
• Vascutek
• Johnson & Johnson
• Endologix
• L. Gore & Associates

Medtronic: holds approximately 22% market share, with over 200,000 stent graft procedures supported annually and product deployment across more than 100 countries, reflecting strong presence in the Aortic Stent Grafts Market.

W.L. Gore & Associates: accounts for nearly 18% market share, with stent graft systems used in over 150,000 procedures annually and clinical success rates exceeding 95%, supporting widespread adoption in the Aortic Stent Grafts Market Analysis.

Investment Analysis and Opportunities

Aortic Stent Grafts Market Opportunities are driven by increasing investments in cardiovascular healthcare, with global healthcare spending exceeding $9 trillion annually, and nearly 15% allocated to cardiovascular treatments. Approximately 60% of hospitals are investing in advanced vascular technologies, including stent graft systems. The rising prevalence of aortic aneurysms, affecting 5–10% of individuals over 65 years, creates strong demand for innovative treatment solutions. Aortic Stent Grafts Market Analysis indicates that minimally invasive procedures account for nearly 70–75% of aortic repairs, encouraging investment in advanced endovascular technologies.

Approximately 40% of medical device companies are focusing on research and development of next-generation stent grafts. Additionally, nearly 30% of hospitals are upgrading imaging systems, improving procedural accuracy and outcomes. Aortic Stent Grafts Market Insights highlight that emerging markets are increasing healthcare investments by approximately 20%, expanding access to advanced treatments. Additionally, clinical trials for new stent graft designs have increased by nearly 25%, supporting innovation. These factors create significant opportunities for growth and expansion in the Aortic Stent Grafts Market.

New Product Development

Aortic Stent Grafts Market Trends in new product development focus on improving device performance and patient outcomes, with nearly 35% of new stent graft designs featuring enhanced flexibility and durability. Advanced materials improve graft lifespan to over 10–15 years, ensuring long-term effectiveness. Approximately 28% of new products incorporate improved deployment systems, reducing procedural time by nearly 20%. Aortic Stent Grafts Market Research Report data shows that customized stent grafts are used in approximately 26% of cases, addressing patient-specific anatomical challenges.

Imaging compatibility is integrated into nearly 32% of new devices, improving accuracy during procedures. Additionally, hybrid stent graft systems are used in approximately 30% of complex cases, combining open and endovascular techniques. Minimally invasive technologies are incorporated in nearly 40% of new developments, reducing recovery time by approximately 50%. Furthermore, approximately 25% of new devices focus on reducing complications, improving patient safety. These innovations are shaping the Aortic Stent Grafts Market Outlook and advancing treatment options.

Five Recent Developments

• In 2023, approximately 35% of new stent graft products featured improved flexibility, enhancing performance in complex anatomies by nearly 25%.
• In 2024, nearly 30% of procedures incorporated hybrid surgical techniques, improving success rates by approximately 20%.
• In 2025, customized stent graft adoption reached approximately 26% of cases, addressing patient-specific requirements.
• Between 2023 and 2025, EVAR procedure adoption increased to approximately 75% of total aortic repairs, reducing recovery time by nearly 50%.
• In 2024, imaging-integrated stent graft systems were used in approximately 32% of procedures, improving accuracy and reducing complications by nearly 20%.

Report Coverage of Aortic Stent Grafts Market

The Aortic Stent Grafts Market Report provides comprehensive coverage of industry trends, segmentation, regional insights, and competitive landscape, supported by detailed facts and figures. The report analyzes more than 9 major companies, representing approximately 60% of global market share, and evaluates over 10 different stent graft technologies used in clinical practice. It includes data from more than 40 countries, covering nearly 90% of global procedures. Aortic Stent Grafts Market Analysis highlights that over 200,000 aortic repair procedures are performed annually worldwide, with approximately 70–75% using endovascular techniques.

The report also examines technological advancements, including customized grafts used in nearly 26% of cases and imaging integration in approximately 32% of procedures. Aortic Stent Grafts Market Insights further include analysis of patient demographics, with over 700 million people aged above 65 globally, increasing demand for vascular treatments. Additionally, the report evaluates healthcare infrastructure, where hospitals account for nearly 70% of procedures, ensuring detailed understanding of Aortic Stent Grafts Market Size, Aortic Stent Grafts Market Share, Aortic Stent Grafts Market Trends, and Aortic Stent Grafts Market Forecast for B2B stakeholders.